# Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic

> **NCT04387409** · PHASE3 · COMPLETED · sponsor: **Serum Life Science Europe GmbH** · enrollment: 59 (actual)

## Conditions studied

- Infection, Respiratory Tract

## Interventions

- **BIOLOGICAL:** VPM1002
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04387409
- **Lead sponsor:** Serum Life Science Europe GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-25
- **Primary completion:** 2021-04-28
- **Final completion:** 2021-04-28
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04387409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04387409, "Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04387409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*